Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-15 4:08 pm Purchase | 2024-03-07 | 13G | Mind Medicine (MindMed) Inc. MNMD | Deep Track Capital LP | 6,666,667 9.490% | 6,666,667 (New Position) | Filing History |
| 2024-03-08 4:03 pm Purchase | 2024-02-27 | 13G | Pyxis Oncology, Inc. PYXS | Deep Track Capital LP | 4,184,100 7.870% | 4,184,100 (New Position) | Filing History |
| 2024-02-23 4:48 pm Purchase | 2024-02-14 | 13G | enGene Holdings Inc. ENGN | Deep Track Capital LP | 2,250,000 5.210% | 2,250,000 (New Position) | Filing History |
| 2024-02-14 11:33 am Sale | 2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Deep Track Capital LP | 3,649,726 9.620% | -34,893 (-0.95%) | Filing History |
| 2024-02-14 11:32 am Sale | 2023-12-31 | 13G | 89bio, Inc. ETNB | Deep Track Capital LP | 2,000,000 2.100% | -2,331,499 (-53.83%) | Filing History |
| 2024-02-14 11:31 am Unchanged | 2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Deep Track Capital LP | 3,710,412 5.880% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:02 am Unchanged | 2023-12-31 | 13G | Zura Bio Limited ZURA | Deep Track Capital LP | 4,205,000 9.290% | 0 (Unchanged) | Filing History |
| 2024-02-14 09:01 am Purchase | 2023-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Deep Track Capital LP | 5,378,997 9.900% | 2,066,023 (+62.36%) | Filing History |
| 2024-02-14 08:59 am Sale | 2023-12-31 | 13G | Valneva SE VALN | Deep Track Capital LP | 7,526,807 5.420% | -2,986,458 (-28.41%) | Filing History |
| 2024-02-14 08:58 am Purchase | 2023-12-31 | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 7,522,281 9.990% | 2,940,281 (+64.17%) | Filing History |
| 2024-02-14 08:57 am Purchase | 2023-12-31 | 13G | Terns Pharmaceuticals, Inc. TERN | Deep Track Capital LP | 6,100,000 9.870% | 2,540,000 (+71.35%) | Filing History |
| 2024-02-14 08:56 am Purchase | 2023-12-31 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Deep Track Capital LP | 2,184,440 6.030% | 1,894,118 (+652.42%) | Filing History |
| 2024-02-14 08:56 am Purchase | 2023-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | Deep Track Capital LP | 4,063,676 5.530% | 809,544 (+24.88%) | Filing History |
| 2024-02-14 08:55 am Unchanged | 2023-12-31 | 13G | Silence Therapeutics plc SLN | Deep Track Capital LP | 5,854,740 5.430% | 0 (Unchanged) | Filing History |
| 2024-02-14 08:54 am Purchase | 2023-12-31 | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital LP | 2,992,731 7.100% | 265,125 (+9.72%) | Filing History |
| 2024-02-14 08:53 am Sale | 2023-12-31 | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital LP | 2,044,507 6.790% | -793,311 (-27.95%) | Filing History |
| 2024-02-14 08:52 am Sale | 2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT | Deep Track Capital LP | 224,246 5.220% | -24,680 (-9.91%) | Filing History |
| 2024-02-14 08:52 am Purchase | 2023-12-31 | 13G | Pliant Therapeutics, Inc. PLRX | Deep Track Capital LP | 5,750,000 9.600% | 2,645,493 (+85.21%) | Filing History |
| 2024-02-14 08:51 am Purchase | 2023-12-31 | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 2,997,830 6.180% | 280,659 (+10.33%) | Filing History |
| 2024-02-14 08:50 am Purchase | 2023-12-31 | 13G | Nektar Therapeutics NKTR | Deep Track Capital LP | 1,226,667 9.650% | 406,518 (+49.57%) | Filing History |